Latest Breaking News On - Trisha roy - Page 8 : comparemela.com

By Syndicated Content Jul 12, 2021 | 4:32 PM (Reuters) – The U.S. government on Monday started a review process for national Medicare coverage of Biogen Inc’s Alzheimer’s drug, Aduhelm, that was recently approved by the country’s health regulator. The Centers for Medicare & Medicaid Services expects to give a proposed decision within 6 months and a final decision within 9 months. (https://go.cms.gov/3hzMa6H) (Reporting by Trisha Roy in Bengaluru; Editing by Shounak Dasgupta) ); } return false; }); $( #comments .commentlist .comment-content a ).attr( target , blank ); });

Shounak dasguptaTrisha royBiogen inc alzheimerCenters for medicare medicaid servicesBiogen incMedicaid servicesஷ்ௌுனாக் தாஸ்குப்தாதிரிஷா ராய்பயோஜென் இன்க் முதுமறதிமையங்கள் க்கு மருத்துவ மருத்துவ உதவி சேவைகள்பயோஜென் இன்க்மருத்துவ உதவி சேவைகள்